Protalix BioTherapeutics, Inc. (PLX) — 分析師展望 / 分析師共識目標價為. 基於 7 位分析師評級, 共識為 看漲 — 5 買入, 2 持有.
分析師預估 每股收益(EPS)為 $0.02 和 營收為 $0.05B (下一財年).
每股收益(EPS)歷史表現: 2024: 實際 $0.04 vs 預期 $0.02 (超預期 +166.7%). 2025: 實際 $-0.08 vs 預期 $0.03 (不及預期 -380.3%). 分析師準確度: 1%.
PLX 分析師評級
Buy
基於過去3個月內 7 位分析師對 Protalix BioTherapeutics, Inc. 的評級
EPS 預測 — PLX
1%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.04
vs Est $0.02
▲ 62.5% off
2025
Actual –$0.08
vs Est $0.03
▼ 135.7% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.
營收預測 — PLX
91%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.053B
vs Est $0.054B
▼ 1.0% off
2025
Actual $0.053B
vs Est $0.062B
▼ 17.5% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
